Time to Rethink the Current Paradigm for Assessing Kidney Function in Drug Development and Beyond-Reference-Cited by-同舟云学术

Time to Rethink the Current Paradigm for Assessing Kidney Function in Drug Development and Beyond

Published:2021-12-18 Issue: Volume: Page:
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Sharma Ashish¹,Sahasrabudhe Vaishali²,Musib Luna³,Zhang Steven⁴,Younis Islam³,Kanodia Jitendra⁵

Affiliation:

1. Boehringer Ingelheim Pharmaceuticals Ridgefield Connecticut USA

2. Pfizer Inc. Groton Connecticut USA

3. Gilead Sciences Inc Foster City California USA

4. Takeda Pharmaceuticals Cambridge Massachusetts USA

5. Theravance Biopharma US Inc South San Francisco California USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2489

Reference109 articles.

1. Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk;Wilson S.;J. Clin. Hypertens. (Greenwich),2021

2. Notice

3. Centers for Disease Control and Prevention.Chronic Kidney Disease Surveillance System—United States (May 17 2021). Accessed August 1 2021.

4. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet,2020

5. Clinical practice guidelines for chronic kidney disease in adults: part II. Glomerular filtration rate, proteinuria, and other markers;Johnson C.A.;Am. Fam. Physician,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Measured and Estimated GFR for Rivaroxaban Dosing in Hospitalized Older Adults;American Journal of Kidney Diseases;2024-01

2. Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study;International Journal of Clinical Pharmacy;2023-12-27

3. Practical Guidance for the Management of Adverse Events in Patients with KRASG12C-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib;The Oncologist;2023-03-09

4. Estimation of glomerular filtration rate for drug dosing in patients with very high or low body mass index;Clinical and Translational Science;2022-07-02